- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07219706
- Original Trial
Dietary Fiber and Time Restricted Eating (FIBER+TRE)
July 1, 2026 updated by: University of Oklahoma
Examining the Independent and Combined Effects of Dietary Fiber and Time Restricted Eating on Indicators of Cancer Risk: the Fiber and Time Restricted Eating (F.I.T.) Study
This study is seeking to examine combinations of two different dietary interventions on cancer risk.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43230
- University of Oklahoma Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- ≥18 age
- Body mass index ≥30 kg/m2
- Dietary fiber intake ≤15 g/day
- Compatible cell phone for use of ecological momentary assessment app
Exclusion Criteria:
- Self-reported diagnosis that precludes fiber intake (e.g., inflammatory bowel disease)
- Food allergies or intolerances that limit ability to engage with the intervention
- Positive screen on the SCOFF eating disorder screener39
- Current self-reported use of GLP-1 receptor agonists
- Currently pregnant or breastfeeding, or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Time Restricted Eating (TRE)
|
10-hour Time Restricted Eating (TRE)
|
|
Experimental: Fiber for Improvement of Behavior, Eating, and Risk (FIBER)
|
Group education about dietary fiber
Counseling and motivational interviewing to promote uptake of diet changes
|
|
Experimental: FIBER and TRE
|
Group education about dietary fiber
Counseling and motivational interviewing to promote uptake of diet changes
10-hour Time Restricted Eating (TRE)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary fiber intake
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Dietary fiber intake as reported on 3-day diet records and analyzed according to Nutrition Data System for Research; reported as a mean intake over three days in grams per day
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass/weight
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Body mass/weight will be measured in kilograms
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
|
Blood-based measures of inflammation
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Venous blood samples will be collected and analyzed for inflammatory markers: Granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-γ), interleukin-1 beta (IL-1β), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α).
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
|
Blood-based measures of oxidative stress
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Venous blood samples will be collected and analyzed for measures of oxidative stress, including reactive oxygen species and lipid peroxidation
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
|
Blood-based measures of insulin resistance
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Insulin resistance will be measured via assessment of insulin and glucose in venous blood samples, and used to assess Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
|
Affect
Time Frame: Daily for three months
|
Self-reported affect will be assessed using ecological momentary assessment, delivered via cell phone
|
Daily for three months
|
|
Sleep
Time Frame: Daily for three months
|
Sleep will be measured via Fitbits, assessed as mean minutes/night
|
Daily for three months
|
|
Physical Activity
Time Frame: Daily for three months
|
Physical activity will be measured via Fitbits, assessed as mean steps/day
|
Daily for three months
|
|
Blood pressure
Time Frame: Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Blood pressure (systolic and diastolic) will be measured at each time frame (in millimeters of mercury [mmHg])
|
Baseline, post-intervention (approximately 3 months), and post-observation (approximately 12 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2025
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Study Registration Dates
First Submitted
October 20, 2025
First Submitted That Met QC Criteria
October 20, 2025
First Posted (Actual)
October 22, 2025
Study Record Updates
Last Update Posted (Actual)
July 6, 2026
Last Update Submitted That Met QC Criteria
July 1, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Body Weight
- Body Weight Changes
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Behavior, Animal
- Weight Loss
- Feeding Behavior
- Fasting
- Intermittent Fasting
- Health Services
- Health Care Facilities Workforce and Services
- Community Health Services
- Behavioral Disciplines and Activities
- Mental Health Services
- Counseling
Other Study ID Numbers
- 18665
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Prevention
-
University of Puerto Rico Comprehensive Cancer...CompletedBreast Cancer Prevention | Colorectal Cancer Prevention | Cervical Cancer PreventionPuerto Rico
-
The University of Texas Health Science Center,...Cancer Prevention Research Institute of TexasRecruiting
-
German Cancer Research CenterUniversity of Music, Drama, and Media HannoverCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingCancer PreventionUnited States
-
German Cancer Research CenterUniversity of Music, Drama, and Media HannoverCompleted
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsNot yet recruitingStep up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among NigeriansCancer PreventionNigeria
-
Case Comprehensive Cancer CenterCompleted
-
IWK Health CentreLaval University; Canadian Association of Fire ChiefsActive, not recruiting
-
HealthPartners InstituteCompleted
-
AshtaYoga, LLCColumbia University; University Of Nigeria Teaching Hospital; Project PINKBLUE... and other collaboratorsCompletedCancer PreventionNigeria
Clinical Trials on Group education
-
Oregon Health and Science UniversityEnrolling by invitation
-
Suleyman Demirel UniversityNot yet recruitingEducational Interventions | Palpation Skills | Physical Therapy Education | Health Professions Education
-
Selcuk UniversityCompletedPain | Fear of Childbirth | Self-Efficacy | Childbirth EducationTurkey (Türkiye)
-
Selcuk UniversityNot yet recruiting
-
The University of Hong KongThe Hong Kong Jockey Club Charities Trust; Hong Kong Island Women AssociationUnknownPhysical Activity | Well-being | Healthy Diet | FamilyHong Kong
-
Norwegian University of Science and TechnologyNorwegian Council for Mental Health; St. Olavs Hospital; Norwegian Foundation...Completed
-
Memorial University of NewfoundlandHealth Care Foundation, NL, Canada; Association of Registered Nurses of Newfoundland... and other collaboratorsCompleted
-
Amasya UniversityEnrolling by invitation
-
Antalya Bilim UniversityActive, not recruitingPregnancy | Maternal Health | Breastfeeding | Infant Care | Newborn Care | TheoryTurkey
-
FATOŞ UNCUCompletedPublic Health NursingTurkey